Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
This Item 5.07 disclosure reports the final voting results from Arvinas' June 24, 2026 annual meeting of stockholders on three proposals: election of two Class II directors (Leslie V. Norwalk, Esq. and Randy Teel, Ph.D.), advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. The filing presents tabulated vote counts (For, Against, Abstain, Broker Non-Votes) for each proposal, which is the standard format for shareholder vote result disclosures under Item 5.07.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-25
Item 1.01
Ingredion entered into a $1.475 billion Delayed Draw Term Loan Agreement on June 24, 2026, to finance its announced acquisition of Tate & Lyle PLC, refinance Tate & Lyle's debt, and cover acquisition-related fees and expenses.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-06-25
Item 7.01
Ellington Financial announced its estimated book value per share of $13.49 as of May 31, 2026, along with a monthly dividend of $0.13 per share. This is a financial disclosure of net asset value and dividend information material to shareholders of a mortgage REIT, but it does not fit the specific categories of earnings_release (no full quarterly/annual results), dividend_distribution (the dividend was previously announced), or other named financial event types. The disclosure is clearly financial in nature and material to investors assessing the company's value, making financial_other the most appropriate classification.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-25
Item 2.02
This is a clear earnings release disclosing Quantum Corporation's fiscal fourth quarter and full year 2026 financial results as of March 31, 2026. The Item 2.02 section explicitly states "Quantum Corporation (the 'Company') reported its financial results for the fiscal quarter ended March 31, 2026" with the earnings release furnished as Exhibit 99.1. The exhibit contains detailed financial statements, revenue growth of 27% year-over-year, and forward guidance for Q1 FY2027, all hallmarks of a quarterly earnings disclosure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-06-25
Item 1.01
Floor & Decor's subsidiary F&D entered into two new senior secured credit facilities on June 24, 2026: a $200 million term loan facility maturing in 2033 and an $800 million revolving ABL facility maturing in 2031, refinancing and replacing its prior term loan and ABL facilities. The transaction creates $1 billion in new direct financial obligations with specified interest rates, maturity dates, covenants, and security interests.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-25
Item 5.07
Marvell held its Annual Meeting of Stockholders on June 25, 2026, with voting results showing all seven director nominees elected, advisory say-on-pay approval, ratification of Deloitte & Touche LLP as auditor, and rejection of a stockholder proposal on independent board chairman.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-06-25
Item 8.01
Marvell declared a quarterly dividend of $0.06 per share, payable on July 30, 2026 to stockholders of record as of July 10, 2026.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Rhythm Pharmaceuticals' Annual Meeting of Stockholders held on June 24, 2026. The filing presents voting outcomes for three proposals: election of two Class III Directors (David W. J. McGirr and David P. Meeker, MD), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed. Shareholder votes on director elections and auditor ratification are material governance events affecting investor assessment of board composition and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
Gates Industrial shareholders approved a scheme of arrangement to redomicile the company from England and Wales to Bermuda at Court and General Meetings held on June 25, 2026, including approval of the Scheme, reduction of capital, issuance of new shares on a one-for-one basis, and articles amendments.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-25
Item 7.01
Gates Industrial shareholders approved a redomiciliation scheme involving a change of domicile from England and Wales to Bermuda with issuance of new shares on a one-for-one basis, constituting a material change of control and corporate restructuring.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-25
Item 8.01
Gates Industrial disclosed the implementation timeline for the shareholder-approved redomiciliation, including court hearing dates, scheme record time, delisting of existing shares, and listing of new shares on the Bermuda exchange.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-06-25
Item 7.01
James Hardie redeemed US$400 million of 5.00% Senior Unsecured Notes due 2028 on June 25, 2026. While this is technically a debt retirement rather than issuance, the redemption of a material debt obligation represents a significant financial event affecting the company's capital structure and liquidity position. The materiality of the $400 million principal amount and the public announcement via press release indicate this is a material disclosure to investors regarding the company's direct financial obligations.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 23, 2026, filed under Item 5.07. The filing reports voting outcomes for three proposals: election of directors Michael Alfred and Lyn Alden, advisory approval of named executive officer compensation, and ratification of Grant Thornton LLC as independent auditors, with detailed vote tallies for each matter. This is a material governance event affecting investor understanding of board composition and shareholder approval of key corporate matters.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-25
Item 5.02
Daren Thayne, Chief Technology Officer and Executive Vice President of Product, notified the Company of his resignation effective July 10, 2026, to accept another executive position. This is a clear departure of a named executive officer. While the filing notes the company does not plan to immediately replace him due to potential transaction negotiations, the principal disclosed action is the officer's departure, making exec_departure the most salient classification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
Item 5.02
Sudhanshu Priyadarshi was appointed as Chief Financial Officer and President, International, effective June 25, 2026. The appointment includes compensatory arrangements with a base salary of $900,000, target bonus of 115%, and equity awards totaling $7,000,000. Tom Fitzgerald's role as Interim CFO concluded with this appointment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-25
Item 5.02
The filing discloses both the resignation of Ms. Dandan Chen as Director and CEO and the election of Liao Xiu Ze as CEO. While both events occur, the principal disclosed action centers on the appointment of a new CEO—Liao Xiu Ze was elected to the CEO role in addition to his existing CFO, Treasurer, and Secretary positions. This is a material leadership transition affecting the company's chief executive officer position.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-25
EX-99.1
This press release announces pivotal Phase II clinical trial results for fanregratinib (HMPL-453) in intrahepatic cholangiocarcinoma, demonstrating an objective response rate of 42.5% and median overall survival of 16.6 months. The trial has met its primary endpoint, and the New Drug Application has been accepted for priority review by China's NMPA in December 2025. This is a material clinical and regulatory milestone for a key drug candidate, but it is not a discrete financial event (earnings release), M&A activity, executive change, or other specifically enumerated event type—it is a significant operational/clinical development that would affect investor assessment of the company's pipeline and commercial prospects.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 75%
filed 2026-06-25
Lloyds Banking Group announces redemption of $1.5 billion in 5.985% Senior Callable Fixed-to-Fixed Rate Notes due 2027 and $500 million in Senior Callable Floating Rate Notes due 2027, to be redeemed on August 7, 2026 at 100% of principal plus accrued interest. While technically a redemption (retirement) of existing debt rather than issuance of new debt, this represents a material modification of the Group's direct financial obligations and capital structure. The redemption of $2 billion in aggregate principal is a significant financial event affecting the Group's debt profile and liquidity position.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-25
Item 1.01
WidePoint was selected as the single awardee of a 10-year DHS Cellular Wireless Managed Services (CWMS) 3.0 contract with a ceiling value of approximately $3.1 billion. While this is technically a government contract award rather than a traditional M&A transaction, it represents a material entry into a definitive agreement that will substantially alter the company's business scope and revenue trajectory. The Item 1.01 classification and the contract's scale ($3.1B ceiling) support treating this as a material business development event most closely aligned with ma_activity in the taxonomy.
View raw filing on EDGAR →
6-K
Operational Other
confidence 72%
filed 2026-06-25
Barclays PLC discloses the Federal Reserve Board's publication of annual bank stress test results for Barclays US LLC, noting that projected capital ratios remained above regulatory minimum levels across all nine quarters tested. This is a regulatory compliance disclosure of material supervisory stress-test results that would affect a reasonable investor's assessment of the registrant's capital adequacy and regulatory standing, but it does not fit neatly into the standard event taxonomy (not a restatement, impairment, covenant breach, or going-concern disclosure). It is operational/regulatory in nature rather than a discrete financial event.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-25
Item 2.03
The filing discloses the creation of a direct financial obligation through the issuance of consolidated obligation bonds. Schedule A reports a $100 million fixed-rate bond (CUSIP 3130BBBR5) with a trade date of 6/22/2026 and maturity of 10/7/2027, representing a new debt obligation for which the Federal Home Loan Bank of New York is the primary obligor. This is a classic debt issuance disclosure under Item 2.03.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 3.02
Beyond Meat entered into warrant agreements with Big Geyser on June 22, 2026, granting rights to purchase up to 4,166,667 shares of common stock at exercise prices of $0.60 and $0.001 per share through a private placement relying on Section 4(a)(2) exemption. The warrants feature weighted average anti-dilution provisions and net-share settlement options, representing a dilutive equity financing arrangement.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-25
Item 8.01
The filing discloses entry into a Binding Memorandum of Understanding to acquire a 51% controlling interest in ULTRANET Telecom Group, described as "the largest transaction in IQSTEL's history." The transaction is expected to add $130M in annual revenue (~30% increase), $4.5M in net income (~4x multiplier), and $13M in shareholders' equity. This is a material acquisition meeting the definition of ma_activity under Item 8.01 (Other Events), though typically such transactions are disclosed under Item 1.01 or 2.01.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
Item 5.02
Keros Therapeutics appointed Anne Prener, M.D., Ph.D., as a director effective July 1, 2026. Dr. Prener brings significant clinical development and executive leadership experience to the Board. Her compensation package includes initial and annual equity grants totaling $300,000 in grant-date fair value plus a $41,500 annual cash retainer.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-25
Item 1.01
Unusual Machines announced a planned acquisition of Upgrade Energy, expected to close by mid-Q3 2026. The company simultaneously entered into a lease for a 14,000-square-foot manufacturing facility in Orlando, Florida to expand domestic battery production capacity in connection with the anticipated acquisition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
Item 5.02
Craig Harris was appointed as a director of Kinetik Holdings Inc., effective June 23, 2026, increasing the Board size from 10 to 11 directors. Harris brings 30+ years of energy industry experience and senior leadership roles at Blackstone, Enable Midstream Partners, and El Paso Corporation.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-25
Item 1.01
Liberty Energy entered into a $332.6 million equipment supply contract with Wärtsilä for power generation equipment to support prospective data center and distributed power projects. While this is a material contract disclosed under Item 1.01, it does not constitute a merger, acquisition, disposition, or change of control (which would be `ma_activity`), nor does it fit other specific financial or operational categories. The contract is a significant capital commitment for strategic business expansion, making it a material operational event that does not fit a named taxonomy category.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-06-25
Item 8.01
FirstSun completed the sale of approximately $336 million in performing municipal loans acquired from First Foundation Bank and intends to use proceeds to pay down high-cost deposits. This is a material balance sheet repositioning activity following the First Foundation acquisition (closed April 1, 2026), affecting asset composition and liability management. While the sale itself is a financial transaction, it does not fit the specific categories of debt_issuance, dividend_distribution, or material_impairment; it is best classified as a material financial event outside those named categories.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-25
Item 1.01
T Stamp Inc entered into a Note Purchase Agreement with Streeterville Capital LLC on June 25, 2026, issuing a Secured Promissory Note with a principal amount of $5,510,000 (net proceeds of $5,000,000) at 9% per annum, maturing June 25, 2028, and secured by all company assets. This represents a material creation of a new direct financial obligation with significant debt covenants and default triggers.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-25
Item 5.07
This Item 5.07 disclosure presents the final voting results from Columbia Financial's annual meeting of shareholders held on June 25, 2026, covering eight distinct proposals including approval of a conversion and merger plan, director elections, auditor ratification, and executive compensation votes. The Columbia Conversion Proposal and Columbia Merger Proposal—both material M&A transactions—received overwhelming shareholder approval (97.6M and 97.6M votes FOR, respectively), making this a material shareholder vote result that would affect investor assessment of the company's strategic direction.
View raw filing on EDGAR →
8-K
M&A activity
confidence 88%
filed 2026-06-25
Item 1.01
VisionWave completed Stage 2 and Stage 3 closings of an exchange transaction with SaverOne on June 22, 2026, acquiring approximately 41% ownership of SaverOne's outstanding shares and entering into an Assignment of Exchange Rights agreement with Adrian Holdings that restructured the Company's financial obligations and equity interests, including assignment of approximately 14.8 billion SaverOne ordinary shares and reduction of a $10 million promissory note by ~$1.43 million.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 3.02
VisionWave issued 1,331,637 shares of common stock to SaverOne as consideration under an Exchange Agreement, with aggregate value of approximately $4.26 million across two closings, in reliance on Section 4(a)(2) and Rule 506(b) exemptions as an unregistered private placement to an accredited investor.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 92%
filed 2026-06-25
The 6-K discloses that WF International has regained compliance with Nasdaq Listing Rule 5550(a)(2) after a prior deficiency notice on December 24, 2025 for failing to maintain the $1.00 minimum bid price for 30 consecutive business days. While the company has now cured the deficiency, the disclosure of the prior non-compliance and the 180-day cure period granted (until June 22, 2026) constitutes a material delisting risk event that would have affected investor assessment during the compliance period. The resolution of this matter is material to investors monitoring the company's continued listing status.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-25
Item 5.02
Alberto Capriles, Senior Executive Vice President and Chief Risk Officer, notified the Company on June 24, 2026 of his plan to retire effective upon appointment of his successor. This is a clear departure of a named executive officer from a material C-suite position (Chief Risk Officer). While the filing notes he will assist with transition, the principal disclosed action is his retirement from the role.
View raw filing on EDGAR →
8-K
Workforce Reduction
confidence 95%
filed 2026-06-25
Item 7.01
The CEO's X post discloses a workforce reduction of approximately 15%, citing strategic refocus on security, trading, stablecoins, settlement, and AI infrastructure. This is a material operational restructuring that would affect investor assessment of the company's cost structure, headcount, and strategic direction. The disclosure is made through Regulation FD and represents a significant organizational change.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-25
Item 1.01
NFE Brazil, a subsidiary of New Fortress Energy Inc., issued $973.5 million aggregate principal amount of 12.000% Senior Secured Notes due 2029 on June 19, 2026. The proceeds are to be used for refinancing approximately $477 million of existing indebtedness and funding operations, capital expenditures, and restructuring costs.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 97%
filed 2026-06-25
Item 2.03
Robinhood completed a private offering of $2.2 billion in aggregate principal amount of 0.00% convertible senior notes due 2029, creating a material direct financial obligation. The notes are convertible into up to 20,811,560 shares of Class A common stock and were issued under Section 4(a)(2) and Rule 144A exemptions. Net proceeds of approximately $2.169 billion were used for share repurchases ($290 million), capped call transactions ($123.2 million), and general corporate purposes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting held on June 25, 2026. The filing reports voting outcomes on three proposals: election of three Class II Directors, approval of an amendment to the 2024 Equity Incentive Plan to increase available shares, and ratification of CBIZ CPAs P.C. as independent auditor. The detailed vote tallies (Votes For, Against, Withheld, Abstentions, and Broker Non-Votes) for each proposal are the hallmark of Item 5.07 disclosure and constitute material shareholder governance events.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-25
Item 2.02
American Outdoor Brands issued a press release on June 25, 2026 reporting financial results for the fiscal year ended April 30, 2026, disclosing full-year net sales of $190.5 million (down 14.3% YoY), a GAAP net loss of $9.2 million, and fiscal 2027 guidance of $200–$210 million in net sales. This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's financial performance and outlook.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
This is a classic Item 5.07 disclosure reporting the certified results of Xos's 2026 annual meeting of stockholders held on June 23, 2026. The filing presents voting outcomes on six proposals including director elections, auditor ratification, equity plan amendment, executive compensation advisory vote, compensation vote frequency, and approval of dilutive convertible note issuance. The disclosure of shareholder vote results is material to investors as it confirms governance actions and shareholder approval of significant matters including a potential 20%+ dilutive issuance.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-25
Item 1.01
The filing discloses completion of a material disposition: Ulixe Italy sold 100% of its equity interests in Ulixe Nova to Condotti Capital S.r.l. on June 18, 2026, pursuant to a Transfer Agreement. The Board explicitly considered this disposal as part of the Company's strategic reorganization in anticipation of its Nasdaq uplisting, and the transaction eliminated future funding obligations and administrative burdens. This is a completed material acquisition/disposition activity under Item 1.01.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-25
EX-99.1
This press release announces the closing of a US$50 million underwritten public offering of 10,309,280 common shares at US$4.85 per share. The offering was conducted pursuant to a prospectus supplement and Form F-10 registration statement filed with the SEC, representing a material dilutive issuance of equity securities. The proceeds are earmarked for clinical development programs and working capital, making this a significant capital-raising event for the clinical-stage pharmaceutical company.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-25
Item 5.03
The Company filed a Certificate of Designation on June 24, 2026, creating 150,000 shares of Series B Convertible Preferred Stock with a conversion price of $1.25 per share, following stockholder approval on June 23, 2026. The Series B Preferred Stock is convertible into Common Stock and represents a dilutive issuance to Omnia pursuant to the Omnia Venture Agreements.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
Finwise Bancorp held its Annual Meeting of Shareholders on June 25, 2026, with voting results on three proposals: election of directors Gerald E. Cunningham and Lisa Ann Nievaard, approval of an amendment to the 2019 Stock Plan increasing available shares by 750,000 to 2,530,000 total, and ratification of Baker Tilly US, LLP as independent auditor. All proposals received shareholder approval with detailed vote tallies disclosed.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-25
Item 8.01
Core & Main announced the launch and pricing of a $750 million offering of 6.000% Senior Notes due 2034 by its subsidiary Core & Main LP. This represents the creation of a new direct financial obligation through debt issuance. The company disclosed both the commencement and pricing of the offering on June 25, 2026, with expected closing on July 1, 2026. The proceeds will be used to prepay existing senior term loan debt and for general corporate purposes including M&A and share repurchases.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-25
Item 5.02
Andrew Liang resigned as a member of the Board of Directors effective June 21, 2026. The disclosure centers on a director's departure from the company, which is a material governance event affecting the composition of the board. The explicit statement that the resignation was not due to disagreement does not diminish the materiality of the departure itself.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
Shareholders voted at the 2026 Annual Meeting of Stockholders held on June 25, 2026, electing seven board directors. All seven nominees received majority approval and will serve as directors until the next annual meeting.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
This Item 5.07 disclosure reports the results of F&G Annuities & Life's Annual Meeting of Shareholders held June 24, 2026, including voting outcomes on three proposals: election of three Class I directors (Rood, Nolan, Martinez), advisory vote on named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. The tabulated vote counts for each proposal are the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-06-25
Item 1.01
Blue Owl NLT entered into a First Amendment to its Amended and Restated Credit Agreement on June 18, 2026, which increases the accordion cap from $5.0 billion to $6.0 billion and modifies borrowing base terms and financial covenants. While this is technically an amendment to an existing credit facility rather than a new debt issuance, it materially expands the company's borrowing capacity and modifies the terms of a direct financial obligation, which aligns with the debt_issuance category's scope of "entry into or amendment of a credit facility." The increase in accordion capacity and relaxation of borrowing restrictions (removal of prohibited use restrictions, expansion to multi-tenant properties) represent material modifications to the company's financing structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
This is a clear disclosure of shareholder voting results from the Company's annual meeting held June 12 and reconvened June 25, 2026. The filing reports final voting tallies for three proposals: election of two Class II Trustees, a Termination Authority Proposal, and ratification of PricewaterhouseCoopers LLP as independent auditor. This is the quintessential Item 5.07 disclosure and is material to investors as it documents shareholder approval of board composition and auditor selection.
View raw filing on EDGAR →